Editorial: Prophylactic efficacy and safety of COVID-19 vaccines in preventing disease caused by various SARS CoV-2 variants.
| Autor: | Mousa HA; College of Medicine, University of Basrah, Basrah, Iraq., Ansari MA; Department of Biotechnology, SCLS, Jamia Hamdard, New Delhi, India.; Centre for Virology, SIST, Jamia Hamdard, New Delhi, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Mar 13; Vol. 14, pp. 1384601. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024). |
| DOI: | 10.3389/fcimb.2024.1384601 |
| Abstrakt: | Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|